We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Research · 8 min read

Is it perimenopause? The 16 symptoms worth tracking (beyond hot flashes)

By Kevin Wolfe, Founder & CEO

Reviewed by Kindr Health Clinical Team

Published · Updated

A newly validated 16-item scale groups perimenopause symptoms into four domains and asks what you have noticed over the past 30 days, well beyond hot flashes. Here's what it covers, what older checklists can miss, and how a month-long log may help a clinician visit.

Hot flashes get most of the headlines. Many people in midlife also notice sleep that falls apart, sex that hurts or recedes, a mood that will not stay even, joints that ache, digestion that changes, hair or skin that feels different, or weight that will not stay put. The question is often the same: is this perimenopause, or something else?

A study published November 10, 2026, in Menopause, the journal of The Menopause Society, reports the validation of a 16-item Perimenopause Symptom Scale, or Peri-SS. Researchers at Flo Health developed the questionnaire with clinical input. The published author list includes Mayo Clinic clinicians Chrisandra Shufelt and Stephanie Faubion. It is a symptom checklist, not a test that can tell you that you are—or are not—in perimenopause. It groups symptoms into four domains—sexual, physical, psychological, and vasomotor—and asks you to rate what you have noticed over the past 30 days.

The four domains, and the 16 items

The authors started with 25 candidate items proposed by gynecologists who specialize in perimenopause and menopause care, then kept 16 after an analysis in a separate group of Flo app users who said they were in perimenopause. The published supplement lists the items, with short notes on what each one is meant to capture. Participants rate each one from none to very severe.

Vasomotor symptoms (two items): hot flashes (sudden heat waves) and night sweats (hot flashes that happen at night).

Psychological and emotional stress (five items): feeling down or sad; irritability; anxiety; physical or mental exhaustion, which the authors say can affect memory, focus, drive, and stamina; and sleep difficulties, such as trouble falling or staying asleep, or waking early.

Sexual health (three items): low sex drive; vaginal dryness; and painful sex, during or after.

Physical and somatic changes (six items): bladder problems, including leaking; joint or muscle pains not related to an injury or another condition; digestive issues, such as bloating or constipation; hair changes, such as hair that feels dry, thin, or brittle; skin changes, such as acne, dryness, or itchiness; and weight changes, including loss or gain.

That is 16 items, which is why the headline keeps that number. It is not a complete catalog of everything people notice in midlife. The authors say headache, fatigue, and brain fog were dropped during development because those items did not perform well statistically. Menstrual cycle changes—often a hallmark of the transition—are not a scored domain either. The team treated irregular cycles as context for identifying perimenopause, not as a symptom on the scale. If your periods have changed, or if you have symptoms the list leaves out, those still belong in a visit.

Why older scales can miss this phase

The Peri-SS paper argues that perimenopause is not simply a milder version of postmenopause. Existing instruments, it says, were often developed to assess postmenopausal women, were built for paper questionnaires, and often leave out symptoms that show up in this phase, including digestive issues and sexual health concerns. The Menopause Rating Scale, or MRS, is the authors' main comparison tool and is widely used. The new scale tracks closely with it overall. But the authors say several commonly reported symptoms—low sex drive, weight changes, and digestive issues—are underrepresented on the MRS.

That is a measurement point, not a claim that those symptoms are always caused by perimenopause, or that a checklist can sort cause from coincidence. Other midlife conditions can look similar. A log may help a clinician see the pattern. It cannot replace that conversation.

The validation study itself was a longitudinal survey of 1,255 women in the United States, ages 35 to 59, recruited online in early 2025. Of them, 633 said they were in perimenopause; that subgroup was used for the main structure and consistency tests. Participants also completed the MRS and a general quality-of-life questionnaire, then repeated the surveys 7 to 14 days later. The authors report strong internal consistency, stable scores over that short interval, a close correlation with the MRS, and scores that moved when the comparison scale did. Reproductive stage was self-reported, not confirmed in a clinic. The sample was English-speaking and recruited online, which the authors say limits how far the findings can be generalized to people with less digital access. Five of the authors are Flo Health employees who hold equity in the company, and a sixth is a Flo Health consultant; the paper discloses this.

How a 30-day log may help a visit

Symptoms in this phase often come and go. The Peri-SS asks about the past 30 days for that reason: long enough to catch things that are intermittent, recent enough to remember. You do not need that particular questionnaire, or a score, to prepare for an appointment. A dated record of what you noticed—hot flashes or night sweats, sleep, mood, pain, bladder or bowel changes, sexual symptoms, hair or skin changes, weight changes, and, importantly, bleeding or cycle changes—may give a clinician a fuller picture than a single hard week or a single good one.

A blood test is not always the first step. In a November 16, 2026, Tufts Now explainer, clinicians interviewed there said hormone testing is not routinely needed to diagnose perimenopause, and that for most otherwise healthy women over 45, a clinical look at symptoms, menstrual history, and age is more useful than a single hormone measurement. Hormone levels also vary across the day and the cycle, which can make one draw hard to interpret. None of that means you should ignore a symptom or treat a diary as a diagnosis. It means a careful history still does a lot of the work.

Bring what you can: when symptoms started, how often they show up, how much they interfere with sleep, work, or sex, what you have already tried, and your other health history. If something on the 16-item list does not apply to you, that is useful too.

If you are thinking about harming yourself or ending your life, or you are in emotional crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or chat at 988lifeline.org. It is free, confidential and available 24/7. If you or someone else is in immediate danger or having a medical emergency, call 911.

Sleep and hot flashes: an association, not a cause

Sleep sits on the Peri-SS psychological list, and night sweats sit on the vasomotor list. They often travel together, which is not the same as one clearly causing the other.

A separate study in Menopause, published October 20, 2026, by researchers at the Australian National University, looked at lifestyle factors and hot flashes in a cross-sectional online survey of women who said they were in perimenopause or postmenopause. The average age was about 56. Everything was self-reported, including sleep, diet, activity, and symptoms. Among the lifestyle measures the team examined, sleep quality had the strongest association with both how often hot flashes occurred and how much they interfered with daily life, after the models accounted for age, menopause status, and ethnicity. Each one-category worsening in reported sleep quality was associated with 2.44 times the odds of being in a higher hot-flash frequency category, and 4.93 times the odds of greater daily interference. Diet quality and physical activity did not show statistically significant associations in the results the authors highlighted.

That study captured people at one point in time. It can describe a pattern. It cannot show that poor sleep causes hot flashes, or that improving sleep will reduce them. Night sweats can wake someone, and more disruptive symptoms may also be reported alongside worse sleep. The relationship may run in more than one direction. If night sweats, poor sleep, or both are getting in the way of your days, that is worth bringing to a clinician, rather than trying to settle the cause at home.

If hormone therapy comes up

A symptom log is not a treatment plan. If you and a clinician talk about hormone therapy, that decision is individual: your symptoms, your health history, your age and timing, and whether a progestogen belongs in the plan if you have a uterus and use systemic estrogen. Hormone therapy isn't right for everyone: depending on age, timing, health history and the type used, it can raise the risk of blood clots, stroke and breast cancer, and estrogen without a progestogen raises the risk of uterine cancer in people who have a uterus.

FDA-approved uses and who should not take hormone therapy are questions for that visit, not for a checklist. We have written in more detail about who should not take hormone therapy, timing and age, and what changed in some boxed warnings. Labeling changes have been product by product, not a blanket statement that hormone therapy has no risks.

Where Kindr fits

At Kindr Health, menopause and midlife care is clinician-led. If you are wondering whether midlife symptoms are part of the transition, a licensed clinician can take a history, talk through what you have been tracking, and discuss options that may or may not include hormone therapy. A 30-day log may make that visit more concrete. It does not replace it. Kindr Care patient intake is open now.

This article is for educational purposes only and is not medical advice. Talk with your clinician before starting, stopping, or changing any medication. See our medical disclaimer.

Sources

  • Xu Y, Ilyich I, Prentice C, Hewings-Martin Y, Cunningham A, Shufelt C, Faubion S, Zhaunova L, "Validation of the Perimenopause Symptom Scale (Peri-SS) for digital self-assessment: psychometric evaluation among US women aged 35 to 59 years," Menopause, published ahead of print November 10, 2026, doi:10.1097/GME.0000000000002948 — doi.org/10.1097/GME.0000000000002948
  • Peri-SS official 16-item instrument, Supplemental Digital Content 1 (linked from the paper as https://links.lww.com/GME/A47) — cdn-links.lww.com/permalink/gme/a/GME_2026_9_23_Xu_MENO-D-26-00267_SDC1.pdf
  • Ranatunga VS, Sutarsa N, Vargas N, Miles KH, Estaphan S, "Lifestyle factors associated with hot flash frequency and daily interference: highlighting the role of sleep quality, diet quality and physical activity," Menopause, published ahead of print October 20, 2026, doi:10.1097/gme.0000000000002899 — doi.org/10.1097/gme.0000000000002899
  • Angela Nelson, "Is menopausal hormone therapy right for you?," Tufts Now, November 16, 2026 — now.tufts.edu/2026/11/16/menopausal-hormone-therapy-right-you
  • 988 Suicide & Crisis Lifeline — 988lifeline.org

Medically reviewed by Kindr Health Clinical Team
Last updated: November 17, 2026

Continue across the Kindr entity graph

Related evidence, peptides, and clinical tools on the same topic.

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Keep reading

Research

Hormone therapy dispensing has more than doubled: what the new JAMA data mean for you

A new JAMA analysis of pharmacy dispensing, as reported by Science News, finds monthly hormone therapy dispensing to women aged 40 to 74 more than doubled since 2023, with growth in transdermal and vaginal estrogen while pills stayed flat, and we look at what that means for planning care

Research

Menopause equity: why so many women still fall through the cracks, and how to get the care you deserve

An AMWA position paper names gaps that still keep people from menopause care: training, screening, coverage, research and stigma. We look at what's changing in state law, a new academic post in British Columbia, and ACOG's guidance, and we offer a practical checklist for getting evaluated.

Research

Menopause care is going mainstream in state law: what's changing on coverage, education and work

Statehouses are moving on menopause coverage, education and work: what Illinois has enacted, what is pending in Pennsylvania, and what to ask your insurer. A federal survey also shows how few symptomatic women ages 40 to 60 currently take a prescription, and we look at how ACOG's new guidance fits in.

Explore your next step

Kindr Care is being updated, and the exact clinical process will depend on the current care pathway.

Explore care options →